Evidence map›Paper›PMID 23412885›Full record

ReviewNeuropsychology review2013

A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders.

Marsha E Bates, Jennifer F Buckman, Tam T Nguyen

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Neuropsychology review, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04057534 (Investigating Neurobiological Mechanisms of Chess as an Add-On Treatment Against Substance Use Disorder), which is not on this map. Cited by 82 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 3 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04057534 nacompletednot on this mapstarted 2020, after this paper: background citation

Investigating Neurobiological Mechanisms of Chess as an Add-On Treatment Against Substance Use Disorder

TypeinterventionalSponsorCentral Institute of Mental Health, MannheimRan2020 to 2023Enrolled108ConditionsSubstance Use DisordersArmsStandard therapy for AUD plus Chess-based cognitive treatment, Standard therapy for AUD, Standard smoking cessation therapy for TUD plus Chess-based cognitive treatment, Standard therapy for TUD
3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 3 syntheses or guidelines pooled it, 208 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marsha E BatesCenter of Alcohol Studies, Rutgers, The State University of New Jersey, 607 Allison Road, Piscataway, NJ 08854-8001, USA. mebates@rutgers.edu
Jennifer F Buckman
Tam T Nguyen
Rutgers, The State University of New Jersey · US

Funding

ALCOHOL, MEMORY AND AFFECTIVE REGULATIONR01AA015248 · NIAAA · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BATES, MARSHA E. · 2004 to 2009
$1.6M
Novel Mechanisms of Behavior Change in Alcoholism TreatmentK02AA000325 · NIAAA · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI BATES, MARSHA E. · 2001 to 2011
$1.3M
THE BAROREFLEX MECHANISM: TRANSLATION TO AUD TREATMENT AND PROGNOSTIC MODELSK24AA021778 · NIAAA · RUTGERS, THE STATE UNIV OF N.J. · PI BATES, MARSHA E. · 2013 to 2017
$830k
EXPLORING GENETIC INFLUENCES ON ALCOHOL USE USING NOVEL STATISTICAL METHODSK01AA017473 · NIAAA · RUTGERS, THE STATE UNIV OF N.J. · PI BUCKMAN, JENNIFER F. · 2009 to 2013
$601k
NIAAA NIH HHS K01 AA017473NIAAA NIH HHS K02 AA000325NIAAA NIH HHS K02 AA00325NIAAA NIH HHS K24 AA021778NIAAA NIH HHS R01 AA015248NICHD NIH HHS HHSN275201000003CNICHD NIH HHS HHSN275201000003I
6 · The paper itself

Abstract

Neurocognitive impairments are prevalent in persons seeking treatment for alcohol use disorders (AUDs). These impairments and their physical, social, psychological and occupational consequences vary in severity across persons, much like those resulting from traumatic brain injury; however, due to their slower course of onset, alcohol-related cognitive impairments are often overlooked both within and outside of the treatment setting. Evidence suggests that cognitive impairments can impede treatment goals through their effects on treatment processes. Although some recovery of alcohol-related cognitive impairments often occurs after cessation of drinking (time-dependent recovery), the rate and extent of recovery is variable across cognitive domains and individuals. Following a long hiatus in scientific interest, a new generation of research aims to facilitate treatment process and improve AUD treatment outcomes by directly promoting cognitive recovery (experience-dependent recovery). This review updates knowledge about the nature and course of cognitive and brain impairments associated with AUD, including cognitive effects of adolescent AUD. We summarize current evidence for indirect and moderating relationships of cognitive impairment to treatment outcome, and discuss how advances in conceptual frameworks of brain-behavior relationships are fueling the development of novel AUD interventions that include techniques for cognitive remediation. Emerging evidence suggests that such interventions can be effective in promoting cognitive recovery in persons with AUD and other substance use disorders, and potentially increasing the efficacy of AUD treatments. Finally, translational approaches based on cognitive science, neurophysiology, and neuroscience research are considered as promising future directions for effective treatment development that includes cognitive rehabilitation.

Indexed as

Alcohol-Related DisordersBrain InjuriesCognition DisordersHumansTreatment Outcome

Identifiers

PMID23412885
PMCPMC3610413
OpenAlexW2038648182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.